NASDAQ:SWKH - Nasdaq - US78501P2039 - Common Stock - Currency: USD
NASDAQ:SWKH (5/22/2025, 8:00:00 PM)
14.14
-0.06 (-0.42%)
The current stock price of SWKH is 14.14 USD. In the past month the price decreased by -4.3%. In the past year, price decreased by -17.89%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HASI | HA SUSTAINABLE INFRASTRUCTUR | 10.55 | 3.08B | ||
BUR | BURFORD CAPITAL LTD | 11.75 | 2.88B | ||
BLX | BANCO LATINOAMERICANO COME-E | 7.22 | 1.50B | ||
ACTG | ACACIA RESEARCH CORP | N/A | 366.58M | ||
SWKHL | SWK HOLDINGS CORP - SWKH 9 01/31/27 | 13.57 | 313.13M | ||
FPAY | FLEXSHOPPER INC | N/A | 31.50M | ||
MCVT | MILL CITY VENTURES III LTD | 10.56 | 12.14M | ||
FTFT | FUTURE FINTECH GROUP INC | N/A | 7.85M | ||
SHFS | SHF HOLDINGS INC | N/A | 6.53M | ||
DXF | EASON TECHNOLOGY LIMITED | N/A | 1.70M |
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 24 full-time employees. The Company’s segments include Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies.
SWK HOLDINGS CORP
5956 Sherry Lane, Suite 650
Dallas TEXAS 75254 US
CEO: Winston L. Black
Employees: 24
Phone: 12142177253
The current stock price of SWKH is 14.14 USD. The price decreased by -0.42% in the last trading session.
The exchange symbol of SWK HOLDINGS CORP is SWKH and it is listed on the Nasdaq exchange.
SWKH stock is listed on the Nasdaq exchange.
7 analysts have analysed SWKH and the average price target is 23.97 USD. This implies a price increase of 69.52% is expected in the next year compared to the current price of 14.14. Check the SWK HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SWK HOLDINGS CORP (SWKH) has a market capitalization of 173.50M USD. This makes SWKH a Micro Cap stock.
SWK HOLDINGS CORP (SWKH) currently has 24 employees.
SWK HOLDINGS CORP (SWKH) has a support level at 13.35 and a resistance level at 14.26. Check the full technical report for a detailed analysis of SWKH support and resistance levels.
The Revenue of SWK HOLDINGS CORP (SWKH) is expected to grow by 6.17% in the next year. Check the estimates tab for more information on the SWKH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SWK HOLDINGS CORP (SWKH) has a dividend yield of 28.29%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of SWKH dividend history, reliability and sustainability.
SWK HOLDINGS CORP (SWKH) will report earnings on 2025-08-12.
The PE ratio for SWK HOLDINGS CORP (SWKH) is 7.52. This is based on the reported non-GAAP earnings per share of 1.88 and the current share price of 14.14 USD. Check the full fundamental report for a full analysis of the valuation metrics for SWKH.
The outstanding short interest for SWK HOLDINGS CORP (SWKH) is 0.52% of its float. Check the ownership tab for more information on the SWKH short interest.
ChartMill assigns a fundamental rating of 5 / 10 to SWKH. SWKH has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months SWKH reported a non-GAAP Earnings per Share(EPS) of 1.88. The EPS increased by 93.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 24.3% | ||
ROA | 4.1% | ||
ROE | 4.72% | ||
Debt/Equity | 0.13 |
ChartMill assigns a Buy % Consensus number of 83% to SWKH. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -13.02% and a revenue growth 6.17% for SWKH